Upgrade to ChromeUpgrade to FirefoxUpgrade to Internet ExplorerUpgrade to Safari

Data Collection and Analysis

Real World Data

While clinical interest invariably focuses on understanding the natural history of disease, payers and providers are required to realise any potential efficiencies of demand management; for example, improving patient throughput in a hospital. Importantly, the same data can provide insight to multiple perspectives. Delivering database analyses that characterise disease progression and healthcare burden, while demonstrating the potential for optimising healthcare delivery, is both efficient and informative.

Influencing Healthcare Decisions

Real world data is a valuable resource. The key to unlocking its full potential is in understanding all stakeholder perspectives and how best to present information that meets their needs, i.e.:

Payers: to minimise cost and maximise health gain

Providers: to increase efficiency and generate income

Clinicians: to maximise quality and quantity of life

Patients: timely access to appropriate healthcare

Routine Health Data

HEOR Ltd has both the methodological and technical expertise to maximise upon the wealth of information available within primary and secondary healthcare databases.

HEOR Ltd has undertaken numerous database analyses to inform Health Economic Modelling, including cost-effectiveness, disease transmission and progression, and health and economic disease burden modelling.

Our experience spans the globe; we have conducted analyses on databases from Europe, the US and Australia. Of note, we routinely work with the CPRD and THIN databases.

Primary Data Collection

To answer your research question, HEOR Ltd can design and implement bespoke surveys, in addition to analysing and reporting their findings. Surveys conducted previously include the quality of life and economic burden of pain, the health outcomes of renal transplantation, and patient satisfaction, costs and outcomes in people with diabetes. HEOR Ltd were co-founders of the Health Outcomes Data Repository (HODaR), which, over the course of the project, elicited data on quality of life, health utility, treatment satisfaction and direct/indirect costs for over 100,000 patients; disease areas covered included diabetes, renal, respiratory, cardiovascular, pain, urology, gastroenterology and orthopaedics.

We design and analyse large scale (including multi-country) patient chart reviews and audits, enabling the compilation of comparative effectiveness data, vital in informing payers and clinicians about the appropriate use of interventions, for example as part of a health technology assessment (HTA).

Market Access and Reimbursement

Chronic hepatitis C virus (HCV) infection is associated with significant morbidity and mortality. The global prevalence of HCV infection has been estimated at 1.6% (1.3–2.1%), equivalent to 115 (92–149) million individuals. Whereas rates of infection are decreasing in the developed world, HCV related liver disease is expected to increase due to the latent nature of early infection and the significant number of undiagnosed cases.

View Case Study

Contact us today to see how we can help

Contact Us